Fate Therapeutics
FATE
#8158
Rank
A$0.30 B
Marketcap
$2.68
Share price
1.20%
Change (1 day)
-46.64%
Change (1 year)

Fate Therapeutics (FATE) - Cash on Hand

Cash on Hand as of September 2024 : A$0.47 Billion

According to Fate Therapeutics 's latest financial reports the company has A$0.47 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Fate Therapeutics - Cash on Hand chart (from 2012 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2023-12-31A$0.46 B-27.83%
2022-12-31A$0.64 B-24.54%
2021-12-31A$0.84 B35.27%
2020-12-31A$0.62 B98.58%
2019-12-31A$0.31 B10.84%
2018-12-31A$0.28 B120.66%
2017-12-31A$0.12 B1.19%
2016-12-31A$0.12 B43.64%
2015-12-31A$88.96 M48.28%
2014-12-31A$59.99 M-0.96%
2013-12-31A$60.57 M592.8%
2012-12-31A$8.74 M40.38%
2011-12-31A$6.22 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
A$1.91 B 303.60%๐Ÿ‡บ๐Ÿ‡ธ USA
A$3.45 B 628.13%๐Ÿ‡บ๐Ÿ‡ธ USA
A$1.61 B 241.29%๐Ÿ‡บ๐Ÿ‡ธ USA
A$2.53 B 435.02%๐Ÿ‡บ๐Ÿ‡ธ USA
A$1.96 B 313.58%๐Ÿ‡บ๐Ÿ‡ธ USA